Gastroenteropancreatic neuroendocrine tumors. Where are we now?

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.30, Iss.1, 2011-03, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraductal Papillary Mucinous Tumors of the Pancreas: Where Are We Now?

International Journal of Gastrointestinal Cancer, Vol. 27, Iss. 3, 2000-06 ,pp. : 181-194

Humana Press, Inc

Access to resources Recommend Favorite

Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center

By Yildiz Ozcan

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1050-1056

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1641-1645

Spandidos Publications

Access to resources Recommend Favorite

Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2996-2998

Spandidos Publications

Access to resources Recommend Favorite

AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 876-888

Spandidos Publications

Access to resources Recommend Favorite